Summary
This filing represents an amendment to McKesson Corp's 10-K annual report for the period ending March 30, 1996, filed on February 12, 1997. As an amendment, it primarily serves to correct or supplement information previously submitted, rather than presenting entirely new financial data. Investors should review the specific changes and their implications on the company's reported financial position and performance for that fiscal year. The context of this filing is historical, offering a look back at McKesson's operations and disclosures from the mid-1990s, a period of significant evolution in the pharmaceutical and healthcare distribution industry.
Key Highlights
- 1This document is an amendment (10-K/A) to McKesson Corp's annual report, indicating prior information may have been revised or supplemented.
- 2The filing pertains to the fiscal period ending March 30, 1996.
- 3It was filed on February 12, 1997, providing updated information after the initial report.
- 4As an amendment, its primary purpose is to correct or add details, not to introduce a new reporting period.
- 5Investors should cross-reference this amendment with the original 10-K filing to understand the nature and impact of the changes.
- 6The filing offers a historical snapshot of McKesson's disclosures from the mid-1990s.
- 7Understanding the specific items amended is crucial for a complete picture of the company's financial reporting for that period.
Frequently Asked Questions
A 10-K/A filing is an amendment to a previously filed annual report (10-K). It is used to correct material errors or omissions found in the original filing or to update information that has changed since the initial filing. It does not represent a new reporting period.
This document is a directory listing and does not contain the specific details of the amendments. To understand the exact changes, one would need to access the linked text file (-97-000500.txt) or the original 10-K filing and compare it with this amended version.
Investors should review amendments to ensure they are working with the most accurate and complete financial and operational information about a company. Amendments can correct errors that might significantly alter the understanding of a company's performance or financial health.
During the period ending in 1996, McKesson was a major distributor of pharmaceuticals and health-related products, as well as a provider of information and services to the healthcare industry. The mid-to-late 1990s were a period of significant growth and consolidation in this sector.